Monday, November 17, 2025

Tag: ILUVIEN

Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations...